CBIS Stock Down 4%: New Member Joins Scientific Advisory Board
While other cannabis companies focus on acquisitions and entering different markets, Cannabis Science (OTCPK:CBIS) continues to develop its clinical trial teams. Earlier today, the US company announced that it has appointed an influential member of ... [Read]
CBIS Stock Down 10% in Recent Weeks: Will It Turn Around?
When valued at $0.05 USD, what appears to be an incremental loss can actually mean a substantial loss in terms of percentages. CBIS stock is experiencing just this, having dropped roughly 10% since last week and ... [Read]
Cannabis Science Receives Overwhelming Response From Mr. Raymond C. Dabney’s Shareholder Loyalty Gift Package; Get Set for Cannabis Science 2019 Black-Tie Dinner Awards Gala
IRVINE, CA, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC:CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces it is receiving an overwhelming response from shareholders registering for Mr. Raymond C. ... [Read]
CBIS Celebrates U.S. Congress Passage of the 2018 Farm Bill and RCD Welcomes All Shareholders to the Loyalty Gift Final
IRVINE, CA, Dec. 24, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC:CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, applauds the U.S. Congress’ passage of the 2018 Farm Bill legalizing the production ... [Read]
CBIS Stock: Stable at 4 Cents but is it a Risk Worth Taking?
Looking at CBIS stock as of late, the interest in this company is clear to see. Though this stock has a very small price tag, it is swapping hands at a big rate. This is ... [Read]
The Cannabis Science Inaugural Black-Tie Dinner Awards Gala Final Planning Underway; Recognizing Major Industry Accomplishments, Killing Cancer, and Awarding Unprecedented Shareholder Loyalty
IRVINE, CA, Nov. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE Cannabis Science, Inc. (OTC:CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the inaugural CBIS Black-tie Gala has ... [Read]
CBIS Re-Appoints Mr. Melvin Foote to Its International Government Affairs Board; Mr. Foote Will Continue to Counsel CBIS as South African Cannabinoid Clinical Studies are Underway
IRVINE, CA, Oct. 24, 2018 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTC:CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the appointment of Mr. Melvin Foote to the Company’s ... [Read]
Cannabis Science, Inc. Appoints Dr. Joe Wilson, an Information Technology and Risk Management Expert, to Its International Government Affairs Board
This Post Was Syndicated Under License Via QuoteMedia IRVINE, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased ... [Read]
Cannabis Science, Inc. Re-Appoints Dr. Brylyne Chitsunge, Pan-African Ambassador for Food Security, and Ms. Julia Royall, Global Health Information Specialist, to Its Revamped Scientific Advisory Board
This Post Was Syndicated Under License Via QuoteMedia IRVINE, CA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased ... [Read]
Cannabis Science, Inc. Appoints Dr. Jermane Bond, Noted Research Scientist, to Its Scientific Advisory Board
This Post Was Syndicated Under License Via QuoteMedia IRVINE, CA, Sept. 21, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is ... [Read]